Pixarbio (OTCMKTS:PXRB) and Planet Fitness (NYSE:PLNT) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, earnings, institutional ownership, profitability, risk and dividends.

Institutional & Insider Ownership

90.8% of Planet Fitness shares are owned by institutional investors. 16.4% of Planet Fitness shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Earnings and Valuation

This table compares Pixarbio and Planet Fitness’ top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Pixarbio $1.97 billion 0.00 -$1.00 million N/A N/A
Planet Fitness $429.94 million 12.63 $33.14 million $0.84 66.23

Planet Fitness has lower revenue, but higher earnings than Pixarbio.

Profitability

This table compares Pixarbio and Planet Fitness’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Pixarbio N/A N/A N/A
Planet Fitness 11.22% -95.97% 8.92%

Risk & Volatility

Pixarbio has a beta of -186.52, indicating that its stock price is 18,752% less volatile than the S&P 500. Comparatively, Planet Fitness has a beta of 0.77, indicating that its stock price is 23% less volatile than the S&P 500.

Analyst Ratings

This is a breakdown of recent ratings and price targets for Pixarbio and Planet Fitness, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Pixarbio 0 0 0 0 N/A
Planet Fitness 0 4 8 0 2.67

Planet Fitness has a consensus target price of $51.85, indicating a potential downside of 6.80%. Given Planet Fitness’ higher possible upside, analysts plainly believe Planet Fitness is more favorable than Pixarbio.

Summary

Planet Fitness beats Pixarbio on 9 of the 11 factors compared between the two stocks.

About Pixarbio

PixarBio Corporation, a specialty pharmaceutical/biotechnology company, focuses on the pre-clinical and clinical development of neurological drug delivery systems for post-operative pain. The company researches and develops delivery systems for drugs, devices, or biologics to treat pain, epilepsy, epilepsy, Parkinson's disease, and spinal cord injury. Its principal product platform is NeuroRelease for the therapeutic release of non-opiate drugs for post-operative, acute, and chronic pain in pre-clinical models. The company is based in Medford, Massachusetts.

About Planet Fitness

Planet Fitness, Inc., together with its subsidiaries, franchises and operates fitness centers under the Planet Fitness name. It operates through three segments: Franchise, Corporate-Owned Stores, and Equipment. The Franchise segment is involved in franchising business in the United States, Puerto Rico, Canada, the Dominican Republic, and Panama. The Corporate-Owned Stores segment operates corporate-owned stores in the United States and Canada. The Equipment segment engages in the sale of fitness equipment to franchisee-owned stores in the United States. As of June 30, 2018, the company had 1,608 stores in 50 states, the District of Columbia, Puerto Rico, Canada, the Dominican Republic, Panama, and Mexico. Planet Fitness, Inc. was founded in 1992 and is headquartered in Hampton, New Hampshire.

Receive News & Ratings for Pixarbio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pixarbio and related companies with MarketBeat.com's FREE daily email newsletter.